课题基金 / 基金详情

Morphology and function of lymphocytes expanded in granular lymphocyte leukemia

Morphology and function of lymphocytes expanded in granular lymphocyte leukemia
颗粒淋巴细胞白血病中淋巴细胞扩增的形态和功能
批准号:
63480280
负责人:
OSHIMI Kazuo
金额:
$3.52万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989

项目摘要

项目成果

OSHIMI Kazuo的其他基金

相关文献

中文摘要
翻译
(1)颗粒淋巴细胞的免疫学特征:颗粒淋巴细胞增生性疾病(GLPD)患者外周血中扩增的淋巴细胞分为CD3+T细胞型和CD3-16+NK细胞型。T-GLPD的发病率为%,低于西方国家。T-GLPD中的GL通常缺乏非MHC限制性细胞毒作用,具有ADCC活性,而NK-GLPD中的GL通常同时具有非MHC限制性细胞毒和ADCC细胞毒作用。抗CD3和抗CD8单抗可抑制T-GLPD的ADCC,提示CD3和CD8抗原对T-GLPD的ADCC有调节作用。GL表达IL-2受体(R)β链,GL的增殖是通过这种受体以自分泌和旁分泌的方式介导的。抗IL-2Pβ单抗可抑制GL的增殖。(2)GL的超微结构:当γ-TCR阳性的GL与K562靶细胞混合后,GL进入K562细胞。这种现象被称为“占优”。在α-β-TCR阳性的T细胞或NK细胞中未发现大疱病。(3)从GLPD患者和纯红细胞再生障碍性贫血(PRCA)患者中获得的GL集落分析抑制正常供者来源的CFU-E集落,GL的上清液也抑制集落形成。由于在CFU-E培养系统中加入抗干扰素γ抗体可消除GL介导的CFU-E抑制,因此干扰素-γ和/或相关物质可能是抑制作用的原因。(4)TCR基因分析大多数T-GLPD患者表现出TCR-β和伽马基因的单克隆性重排,而NK-GLPD患者仍处于生殖系构型。
英文摘要
(1) Immunological characteristics of granular lymphocytes (GL).Lymphocytes expanded in the peripheral blood in patients with granular lymphocyte proliferative disorders (GLPD) are divided into CD3+ T-cell type and CD3-16+ NK-cell type. The incidence of T- GLPD is 64%, the number being lower than western countries. GL in T-GLPD usually lack non-MHC- restricted cytotoxicity and possess ADCC, whereas those in NK-GLPD possess both non-MHC-restricted and ADCC cytotoxicity. ADCC of T-GLPD is inhibited by the addition of anti-CD3 and anti-CD8 monoclonal antibodies (mAb), suggesting that CD3 and CD8 antigens regulate ADCC in T-GLPD. GL express IL-2 receptor (R)beta chain al one , and the proliferation of GL is mediated thorough this R in autocrine and paracrine fashion. Anti-IL-2Pbeta mAb inhibits GL proliferation.(2) Ultrastructure of GLWhen gamma delta-TCR-positive GL and K562 target cells are mixed, the GL enter into K562 cells. This phenomenon is called emperipolesis. Emperipolesis is not found in alpha beta-TCR-positive T cells or NK cells. Further characterization of emperipolesis is under investigation using gamma delta- T-cell clones.(3) Colony assayGL obtained from patients with GLPD and pure red-cell aplasia (PRCA) inhibit normal donor-derived CFU-E colonies, and the supernatants of GL also inhibit the colony formation. Since anti-interferon gamma- antibody added in the CFU-E culture system abrogates the GL-mediated CFU-E inhibition, it is likely IFN-gamma and/or related substance may be responsible for the inhibition.(4) Analysis of TCR genesMost patients with T-GLPD exhibit monoclonal rearrangements of TCR-beta and gamma genes, whereas those with NK-GLPD remain in germ-line configuration.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Kazuo Oshimi: "Granular lymphocyte proliferative disorders: Report of 12 cases and review of the literature" Leukemia 2:617-627, 1988.
Kazuo Oshimi:“颗粒淋巴细胞增殖性疾病:12 例报告和文献综述”Leukemia 2:617-627,1988。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuo Oshimi et al.: "Ti(WT31)-negative, CD3-positive, large granular lymphocyte leukemia with nonspecific cytotoxicity" Blood 71:923-931, 1988.
Kazuo Oshimi 等人:“Ti(WT31) 阴性、CD3 阳性、具有非特异性细胞毒性的大颗粒淋巴细胞白血病”Blood 71:923-931,1988。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shigeru Hoshino: "Flow cytometric analysis of expression of interleukin 2 receptor β chain(p70-75)on various leukemic cells." Blood. in press.
Shigeru Hoshino:“各种白血病细胞上白细胞介素 2 受体 β 链 (p70-75) 表达的流式细胞术分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuo Oshimi: "CTL triggering via CD16 is regulated by CD3 and CD8 antigens:Studies with TCR-αβ^+/cd3^+16^+ and TCR-γδ^+/CD3^+16^+ granular" Submitted.
Kazuo Oshimi:“通过 CD16 触发的 CTL 受 CD3 和 CD8 抗原调节:TCR-αβ^+/cd3^+16^+ 和 TCR-γδ^+/CD3^+16^+ 颗粒的研究”已提交。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Etiology, pathopysiology and treatment of NK cell-lineage leukemias and lymphomas
    • 批准号:
      07457234
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.86万
    • 财政年份:
      1995
    • 负责人:
      OSHIMI Kazuo
    • 依托单位:
    Induction of specific cytotoxicity for autologous leukemic cells by the use of keller T cells and bispecific antibodies
    • 批准号:
      02454522
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $2.3万
    • 财政年份:
      1990
    • 负责人:
      OSHIMI Kazuo
    • 依托单位:
    IL-2-activated lymphocytes lytic for autologous leukemia and lymphoma cells: some problems on their clinical application.